Géraldine Perkins

2.5k total citations
44 papers, 1.6k citations indexed

About

Géraldine Perkins is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Géraldine Perkins has authored 44 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 17 papers in Pathology and Forensic Medicine and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Géraldine Perkins's work include Colorectal Cancer Treatments and Studies (18 papers), Genetic factors in colorectal cancer (17 papers) and Cancer Genomics and Diagnostics (10 papers). Géraldine Perkins is often cited by papers focused on Colorectal Cancer Treatments and Studies (18 papers), Genetic factors in colorectal cancer (17 papers) and Cancer Genomics and Diagnostics (10 papers). Géraldine Perkins collaborates with scholars based in France, United States and United Kingdom. Géraldine Perkins's co-authors include Rocky S. Tuan, Genevieve M. Boland, David J. Hall, Assia Derfoul, David J. Hall, Valérie Taly, Fanny Garlan, Pierre Laurent‐Puig, Wayne A. Johnson and Michael G. Anderson and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and PLoS ONE.

In The Last Decade

Géraldine Perkins

40 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Géraldine Perkins France 17 651 529 458 283 281 44 1.6k
Lu Q. Le United States 27 917 1.4× 218 0.4× 262 0.6× 137 0.5× 242 0.9× 71 2.5k
Zhengjian Yan China 16 1.1k 1.7× 240 0.5× 328 0.7× 151 0.5× 164 0.6× 44 2.1k
Luisa Cironi Switzerland 16 1.2k 1.8× 571 1.1× 486 1.1× 214 0.8× 189 0.7× 22 2.0k
Tong Sun China 22 1.2k 1.8× 414 0.8× 523 1.1× 93 0.3× 111 0.4× 61 2.0k
Mario-Luca Suvà Switzerland 13 1.6k 2.4× 575 1.1× 662 1.4× 204 0.7× 187 0.7× 17 2.4k
Marianna B. Ruzinova United States 15 822 1.3× 504 1.0× 286 0.6× 154 0.5× 138 0.5× 36 1.4k
Takuyu Taki Japan 17 654 1.0× 310 0.6× 186 0.4× 197 0.7× 208 0.7× 63 1.3k
Fumiko Itoh Japan 26 2.2k 3.3× 559 1.1× 279 0.6× 189 0.7× 138 0.5× 56 3.0k
Kei Sakamoto Japan 27 1.4k 2.2× 473 0.9× 358 0.8× 122 0.4× 83 0.3× 88 2.2k
Ken Yagi Japan 22 1.8k 2.8× 360 0.7× 497 1.1× 154 0.5× 206 0.7× 34 2.3k

Countries citing papers authored by Géraldine Perkins

Since Specialization
Citations

This map shows the geographic impact of Géraldine Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Géraldine Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Géraldine Perkins more than expected).

Fields of papers citing papers by Géraldine Perkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Géraldine Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Géraldine Perkins. The network helps show where Géraldine Perkins may publish in the future.

Co-authorship network of co-authors of Géraldine Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of Géraldine Perkins. A scholar is included among the top collaborators of Géraldine Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Géraldine Perkins. Géraldine Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agustí, Núria, et al.. (2025). Trends and clinical predictors in ovarian preservation in patients with low-risk endometrial cancer. American Journal of Obstetrics and Gynecology. 234(3). 650–667.
2.
Perkins, Géraldine, et al.. (2025). Thrombopénie immunologique induite par chimiothérapie : un coupable peut en cacher un autre. La Revue de Médecine Interne. 46(6). 313–319.
3.
Ambrosini, Margherita, David Tougeron, Dominik Paul Modest, et al.. (2024). BRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic colorectal cancer. European Journal of Cancer. 210. 114290–114290. 7 indexed citations
4.
Gelli, Maximiliano, Christophe Desterke, Valérie Boige, et al.. (2023). Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases. Cancers. 15(17). 4418–4418. 1 indexed citations
5.
Perkins, Géraldine, Astrid Pozet, David Tougeron, et al.. (2021). Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study. Clinics and Research in Hepatology and Gastroenterology. 45(5). 101709–101709. 3 indexed citations
6.
Koual, Meriem, Géraldine Perkins, Nicolas Delanoy, et al.. (2020). Syndrome héréditaire de prédisposition au cancer du sein et de l’ovaire : diagnostic et implications thérapeutiques. Annales de Pathologie. 40(2). 70–77. 1 indexed citations
7.
Palmieri, Lola‐Jade, Olivier Dubreuil, Jean‐Baptiste Bachet, et al.. (2020). Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study. Clinics and Research in Hepatology and Gastroenterology. 45(1). 101431–101431. 8 indexed citations
8.
Pellat, Anna, Géraldine Perkins, Romain Cohen, et al.. (2018). Syndrome de Lynch : quoi de neuf ?. Bulletin du Cancer. 106(7-8). 647–655. 17 indexed citations
9.
Garlan, Fanny, Pierre Laurent‐Puig, David Sefrioui, et al.. (2017). Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study). Clinical Cancer Research. 23(18). 5416–5425. 165 indexed citations
10.
Taı̈eb, Julien, Karine Le Malicot, Josep Tabernero, et al.. (2017). Prognostic value of primary tumor location in stage III colon cancer is associated with RAS and BRAF mutational status.. Annals of Oncology. 28. iii142–iii142. 4 indexed citations
11.
12.
Taı̈eb, Julien, Karine Le Malicot, Josep Tabernero, et al.. (2016). Adjuvant FOLFOX+ cetuximab vs FOLFOX in full RAS and BRAF wild type stage III colon cancer patients: Results from the PETACC8 trial. Annals of Oncology. 27. vi152–vi152. 2 indexed citations
13.
Taı̈eb, Julien, Karine Le Malicot, Josep Tabernero, et al.. (2016). Adjuvant FOLFOX +/− cetuximab in fullRAS andBRAF wildtype stage III colon cancer patients. Annals of Oncology. 28(4). 824–830. 40 indexed citations
14.
Perkins, Géraldine, Heng Lu, Fanny Garlan, & Valérie Taly. (2016). Droplet-Based Digital PCR. Advances in clinical chemistry. 79. 43–91. 86 indexed citations
15.
Abitbol, Véred, Didier Borderie, V. Polin, et al.. (2015). Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin Index. Medicine. 94(26). e1011–e1011. 26 indexed citations
16.
Ong, Michael, Suzanne Carreira, Jane Goodall, et al.. (2014). Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail. British Journal of Cancer. 111(5). 828–836. 23 indexed citations
17.
Dior, Marie, Romain Coriat, Olivier Mir, et al.. (2012). A Rare Hematological Adverse Event Induced by Bevacizumab: Severe Thrombocytopenia. The American Journal of Medicine. 125(8). 828–830. 13 indexed citations
18.
Mir, Olivier, Romain Coriat, Marion Dhooge, et al.. (2012). Feasibility of gemcitabine and oxaliplatin in patients with advanced biliary tract carcinoma and a performance status of 2. Anti-Cancer Drugs. 23(7). 739–744. 17 indexed citations
19.
Dréanic, Johann, Romain Coriat, Olivier Mir, et al.. (2012). Cervical extravasation of bevacizumab. Anti-Cancer Drugs. 24(4). 426–428. 4 indexed citations
20.
Perkins, Géraldine, Astrid Lièvre, Tchao Méatchi, et al.. (2010). Additional value of EGFR downstream signaling phosphoprotein expression to KRAS status for response to anti‐EGFR antibodies in colorectal cancer. International Journal of Cancer. 127(6). 1321–1331. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lu Q. Le Breakdown of academic impact, for papers by Zhengjian Yan Breakdown of academic impact, for papers by Luisa Cironi Breakdown of academic impact, for papers by Tong Sun Breakdown of academic impact, for papers by Mario-Luca Suvà Breakdown of academic impact, for papers by Marianna B. Ruzinova Breakdown of academic impact, for papers by Takuyu Taki Breakdown of academic impact, for papers by Fumiko Itoh Breakdown of academic impact, for papers by Kei Sakamoto Breakdown of academic impact, for papers by Ken Yagi
Rankless by CCL
2026